Predict your next investment

Tourye.com company logo
BUSINESS PRODUCTS & SERVICES | HR & Staffing
tourye.com

See what CB Insights has to offer

Total Raised

$7.24M

Investors Count

4

Tourye.com Funding, Tourye.com Valuation & Tourye.com Revenue

3 Fundings

Tourye.com's latest funding round was a Series B for $5.79M on December 10, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/10/2018

Series B

$5.79M

Amer, and Tuniu

1

12/15/2017

Series A - II

10

4/21/2017

Series A

$99M

10

Date

12/10/2018

12/15/2017

4/21/2017

Round

Series B

Series A - II

Series A

Amount

$5.79M

$99M

Investors

Amer, and Tuniu

Valuation

Revenue

Sources

1

10

10

Tourye.com Investors

4 Investors

Tourye.com has 4 investors. Tuniu invested in Tourye.com's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/10/2018

12/10/2018

1
Series B

Corporation

China

00/00/0000

00/00/0000

Amer

Subscribe to see more

Corporation

China

00/00/0000

00/00/0000

Zero2IPO Venture Capital

Subscribe to see more

Corporate Venture

China

00/00/0000

00/00/0000

Huagai Capital

Subscribe to see more

Private Equity

China

First funding

12/10/2018

00/00/0000

00/00/0000

00/00/0000

Last Funding

12/10/2018

00/00/0000

00/00/0000

00/00/0000

Investor

Amer

Zero2IPO Venture Capital

Huagai Capital

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Corporation

Corporate Venture

Private Equity

Location

China

China

China

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.